Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantCombined Modality TherapyAntineoplastic AgentsCisplatinCyclophosphamideDoxorubicinTreatment OutcomeNeoadjuvant TherapyDisease-Free SurvivalBreast NeoplasmsEtoposideNeoplasm StagingSurvival AnalysisPrognosisSurvival RateLung NeoplasmsDrug Administration ScheduleMethotrexateCarboplatinPaclitaxelVinblastineInduction ChemotherapyNeoplasm Recurrence, LocalTaxoidsDrug Resistance, NeoplasmIfosfamideNeoplasmsBleomycinAntimetabolites, AntineoplasticDeoxycytidineOrganoplatinum CompoundsTime FactorsFollow-Up StudiesAnthracyclinesAntineoplastic Agents, AlkylatingCytarabineSalvage TherapyChemotherapy, Cancer, Regional PerfusionCarcinoma, Non-Small-Cell LungNeoplasm MetastasisOvarian NeoplasmsAdenocarcinomaTesticular NeoplasmsVomitingNeutropeniaTransplantation, AutologousNauseaLymphoma, Non-HodgkinAntineoplastic Agents, PhytogenicRadiotherapy, AdjuvantHodgkin DiseaseProspective StudiesColorectal NeoplasmsRadiotherapyAntibiotics, AntineoplasticDose-Response Relationship, DrugClinical Trials as TopicMolecular Sequence DataDacarbazineCarmustineKaplan-Meier EstimateNeoplasms, Germ Cell and EmbryonalCamptothecinGranulocyte Colony-Stimulating FactorLomustineBrain NeoplasmsBone NeoplasmsTumor Markers, BiologicalPlatinum CompoundsOsteosarcomaCell Line, TumorLeukopeniaLiver NeoplasmsMitomycinMelphalanInfusions, Intra-ArterialAntiemeticsRecurrenceInfusions, IntravenousThiotepaDrug TherapyPeritoneal NeoplasmsHematopoietic Stem Cell TransplantationMitoxantroneLymphatic MetastasisStomach NeoplasmsRadiotherapy DosageBiochemical ProcessesPalliative CareAntibodies, Monoclonal, HumanizedTegafurDisease ProgressionRecombinant ProteinsGerminomaCarcinomaAntibodies, MonoclonalDaunorubicinCarcinoma, Squamous CellRandomized Controlled Trials as Topic